TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Drug Overdose/mortality/prevention & control
KW - Family/psychology
KW - Heroin/adverse effects
KW - Humans
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy/mortality
KW - Peer Group
KW - Time Factors
KW - Drug-related deaths
KW - Harm Reduction
KW - naloxone
KW - Opiate
KW - Overdose
KW - prevention
AU - R. McDonald
AU - N. D. Campbell
AU - J. Strang
A1 - 
AD - National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, Addictions Sciences Building, 4 Windsor Walk, Denmark Hill, London, SE5 8BB, United Kingdom.; Department of Science and Technology Studies, Sage Labs 5202, Rensselaer Polytechnic Institute, 110 Eighth Street Troy, NY, 12180, United States.; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, Addictions Sciences Building, 4 Windsor Walk, Denmark Hill, London, SE5 8BB, United Kingdom. Electronic address: john.strang@kcl.ac.uk.
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
CY - Ireland
JF - Drug and alcohol dependence
M1 - Journal Article
PB - Elsevier B.V
PP - Ireland
PY - 2017
SN - 1879-0046; 0376-8716
SP - 176
EP - 187
EP - 
T1 - Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation
T2 - Drug and alcohol dependence
TI - Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation
U1 - Opioids & Substance Use
U2 - 28654870
VL - 178
VO - 1879-0046; 0376-8716
Y1 - 2017
Y2 - Sep 1
ER -